Are you effectively driving awareness of your patient support services? Learn more in the latest blog from UBC’s VP of Patient Access & Strategic Engagement Dana Edwards: https://hubs.li/Q02-7xzn0 #PatientsFirst #PatientSupport #PatientServices #Pharma
UBC
Pharmaceutical Manufacturing
Blue Bell, PA 30,777 followers
Patients First. Powered by Evidence.
About us
United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. Underpinned by our scientific expertise, data and analytics, and innovative technologies, we offer our customers flexible solutions generating the relevant real-world data necessary to make more informed decisions earlier, meet stakeholder requirements, and ultimately, drive better patient outcomes.
- Website
-
http://www.ubc.com
External link for UBC
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Blue Bell, PA
- Type
- Privately Held
- Founded
- 2003
- Specialties
- Evidence Development, Modernized Study Design & Execution, Late-Stage Research, Risk Evaluation & Mitigation Strategies, Pharmacovigilance, Patient Access & Hub Services, Reimbursement & Patient Assistant Programs, and Nursing & Adherence
Locations
Employees at UBC
-
Radhika Rao
Senior Project Manager & Service Delivery Expert | Champion in Vendor Performance Oversight | IT Transformation Specialist | Strategic Leader
-
Rebecca Richardson
GQC CAPA administrator at UBC
-
Troy Mann
Manager - Program Management at UBC
-
Richard LeBoon PhD PCC
Executive Search Leader Connecting Executive Talent with New Career Opportunities and an Executive Leadership Coach Helping Business Leaders Thrive…
Updates
-
Today is the final day of Trade & Channel Strategies 2024! There is still time to meet with UBC’s patient access experts. Schedule a meeting at https://hubs.li/Q02-x4Sm0 #PatientsFirst #Trade2024 #Pharma #PatientAccess
-
-
Day 2 of Trade & Channel Strategies is here! Set up time with our patient access experts to discuss our personalized approach to program design and execution at https://hubs.li/Q02Xc-S30 #PatientsFirst #Trade2024 #Pharma #PatientAccess
-
-
Today kicks off Trade & Channel Strategies! Meet our team to collaborate on channel complexities and explore innovative patient access strategies. https://hubs.li/Q02-x6qz0 #PatientsFirst #Trade2024 #Pharma #PatientAccess
-
-
ASH 2024 is almost over. Make sure to catch UBC’s Evidence Development team before it ends and learn how to empower your hematology drug development through patient-centric services and proven functional expertise. https://hubs.li/Q02ZqZmV0 #RWE #ASH2024 #Hematology
-
-
ASH is an inspiring opportunity for discussing trends and advances in hematology with expert physicians, researchers, and other incredible leaders in the field. If you’d like to speak with UBC’s experts and benefit from our experience supporting 33 unique hematology projects over the last 5 years, visit https://hubs.li/Q02ZpM_l0 #RWE #ASH2024 #Hematology
-
-
While you’re exploring the future of hematology with sessions and poster presentations at ASH 2024, don’t forget to connect with UBC about creating clear, risk-managed pathways to bring your treatments to market. Find out more at https://hubs.li/Q02ZpX7y0 #RWE #ASH2024 #Hematology
-
-
UBC’s evidence development team is in San Diego for ASH 2024, discussing transformative approaches to hematology evidence generation. Learn more, and find out how to meet with us, at https://hubs.li/Q02ZpnjK0 #RWE #ASH2024 #Hematology
-
-
Did you miss the UBC and Novartis presentation on improving your patient service program awareness last month? Dive into the details in our latest blog at https://hubs.li/Q02-3b420 #PatientsFirst #PatientSupport #PatientServices #Pharma
-
-
Are you attending Trade & Channel Strategies? Our patient access experts are excited to meet you! Connect and collaborate with our team at https://hubs.li/Q02XcGM_0 #PatientsFirst #Trade2024 #Pharma #PatientAccess
-